Answers are grounded in this paper and cite their sources.
GS is feasible in clinical practice and reliably identifies causal variants in a substantial proportion of individuals. GS extends the diagnostic yield to rare non-coding variants and enables precise determination of SVs. The added diagnostic value of RNA-seq is limited by low expression levels of the major IRD disease genes in blood.
No takes yet. Share an insight, caveat, or question.
Weisschuh et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: